TIAA CREF Investment Management LLC Sells 118,116 Shares of Kindred Healthcare, Inc. (KND)

TIAA CREF Investment Management LLC cut its stake in shares of Kindred Healthcare, Inc. (NYSE:KND) by 26.1% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 335,155 shares of the health services provider’s stock after selling 118,116 shares during the period. TIAA CREF Investment Management LLC owned 0.39% of Kindred Healthcare worth $2,799,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in KND. Louisiana State Employees Retirement System boosted its stake in Kindred Healthcare by 1.5% in the first quarter. Louisiana State Employees Retirement System now owns 34,700 shares of the health services provider’s stock worth $290,000 after buying an additional 500 shares in the last quarter. Arizona State Retirement System boosted its stake in Kindred Healthcare by 1.1% in the first quarter. Arizona State Retirement System now owns 44,364 shares of the health services provider’s stock worth $370,000 after buying an additional 500 shares in the last quarter. Wedbush Securities Inc. boosted its stake in Kindred Healthcare by 4.3% in the first quarter. Wedbush Securities Inc. now owns 19,300 shares of the health services provider’s stock worth $161,000 after buying an additional 800 shares in the last quarter. Mutual of America Capital Management LLC boosted its stake in Kindred Healthcare by 0.7% in the first quarter. Mutual of America Capital Management LLC now owns 166,733 shares of the health services provider’s stock worth $1,392,000 after buying an additional 1,221 shares in the last quarter. Finally, First Citizens Bank & Trust Co. boosted its stake in Kindred Healthcare by 8.9% in the first quarter. First Citizens Bank & Trust Co. now owns 15,462 shares of the health services provider’s stock worth $129,000 after buying an additional 1,260 shares in the last quarter. Institutional investors and hedge funds own 89.79% of the company’s stock.

Kindred Healthcare, Inc. (NYSE:KND) opened at 7.70 on Friday. The company’s 50 day moving average price is $9.69 and its 200-day moving average price is $9.21. Kindred Healthcare, Inc. has a 12-month low of $5.65 and a 12-month high of $11.90. The stock’s market cap is $670.05 million.

Kindred Healthcare (NYSE:KND) last announced its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.03. Kindred Healthcare had a negative net margin of 16.31% and a positive return on equity of 3.49%. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the firm earned $0.38 EPS. The company’s revenue for the quarter was down 4.6% compared to the same quarter last year. On average, analysts forecast that Kindred Healthcare, Inc. will post $0.53 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “TIAA CREF Investment Management LLC Sells 118,116 Shares of Kindred Healthcare, Inc. (KND)” was first reported by BNB Daily and is owned by of BNB Daily. If you are reading this news story on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this news story can be viewed at https://www.baseball-news-blog.com/2017/08/19/kindred-healthcare-inc-knd-position-decreased-by-tiaa-cref-investment-management-llc-updated-updated.html.

KND has been the topic of a number of analyst reports. Zacks Investment Research upgraded Kindred Healthcare from a “hold” rating to a “buy” rating and set a $11.00 price target on the stock in a research note on Wednesday, May 3rd. Royal Bank Of Canada reaffirmed a “hold” rating and set a $10.00 price objective on shares of Kindred Healthcare in a report on Monday, May 15th. Barclays PLC reaffirmed a “buy” rating and set a $13.00 price objective (up previously from $11.00) on shares of Kindred Healthcare in a report on Sunday, May 7th. BidaskClub lowered Kindred Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, July 12th. Finally, Deutsche Bank AG dropped their price objective on Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating on the stock in a report on Monday, August 7th. Four research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $9.94.

About Kindred Healthcare

Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Institutional Ownership by Quarter for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply